Overview

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Status:
Completed
Trial end date:
2022-01-10
Target enrollment:
Participant gender:
Summary
Our trial goal is to determine the efficacy and safety of sitagliptin in comparison with empagliflozin in type 2 diabetic Egyptian patients.
Phase:
N/A
Details
Lead Sponsor:
Sadat City University
Collaborator:
Beni-Suef University
Treatments:
Dipeptidyl-Peptidase IV Inhibitors
Empagliflozin
Sitagliptin Phosphate
Sodium-Glucose Transporter 2 Inhibitors